Fludarabine, Cytarabine, G-CSF and Gemtuzumab Ozogamicin (FLAG-GO) Regimen Results in Better Molecular Response and Relapse-Free Survival in Core Binding Factor Acute Myeloid Leukemia Than FLAG and Idarubicin (FLAG-Ida)
暂无分享,去创建一个
H. Kantarjian | G. Garcia-Manero | J. Cortes | K. Patel | T. Kadia | F. Ravandi | G. Borthakur | E. Jabbour | N. Daver | M. Ohanian | M. Brandt | G. Issa